Recent posts

Making Mass Analysis Smarter for Biopharma

By March 12, 2019

There’s no question that we’ve entered the age of smart technology. Your phone, your home, your refrigerator, even your light bulbs are all getting smarter. Such technologies do more and more to run themselves, removing… Read more >

Categories: Pharmaceutical
Tags:

The Future of Biopharmaceutical Development Just Became Brighter

By February 28, 2019

In late January, I traveled to WCBP (Well Characterized Biological Products), an industry conference that is hosted every year by the CASSS organization. It serves as a forum that brings together biopharmaceutical industry professionals and… Read more >

Categories: Pharmaceutical
Tags: ,

Method Lifecycle Management Survey Reveals Barriers and Enthusiasm for Change

By January 23, 2019

Waters recently surveyed 100 method developers from innovator and generic pharmaceutical companies to better understand their existing challenges and views on Method Lifecycle Management (MLCM). We’ll share with you the top questions and findings from our survey results.

Categories: General, Pharmaceutical
Tags: , , , , ,

Routine Mass Analysis Enables Greater Productivity in Biopharma Development

By January 15, 2019

Its great promise for routine monitoring of biologic drugs begs the question: Just when will LC-MS analysis become a true bedrock analytical tool for scientists and technicians throughout biopharma?

Categories: Pharmaceutical
Tags: , , ,

Enhancing Analytical Productivity by Breaking Down Silos – Part 3

By January 9, 2019

Analytical data can be so much more than a historical point in time documented in a single report. In fact, biopharmaceutical organizations can use LC-MS data to build a continuum of compliance.

Categories: Pharmaceutical
Tags: , , , , , , , , , ,

Future-Proofing Pharmaceutical R&D to Accelerate Aerosol Science Innovation

By November 30, 2018

At Chiesi Group’s Chippenham laboratory in the UK, Waters’ UPLC systems with mass detection and informatics keep the team at the forefront of inhalation drug delivery products.

Categories: Customer Stories, Pharmaceutical
Tags: , ,

Enhancing Analytical Productivity by Breaking Down Silos (Part 2)

By October 30, 2018

For biopharmaceutical organizations working with contract labs, it’s important to consider how data and methods will be transferred and how generated data will be managed so that it meets data integrity and compliance requirements.

Categories: Pharmaceutical
Tags: , , , , , , ,

Oligonucleotide Analysis Supports Exciting Therapeutic Approach

By October 22, 2018

In Japan, Professor Masanori Kataoka finds that the ACQUITY QDa Mass Detector is suitable for the synthesis and analysis of oligonucleotides – and sees ways to expand its use.

Categories: Pharmaceutical
Tags: , , ,

Webinar Highlights – Pharmacopeial Modernization: How Will Your Chromatography Workflow Benefit?

By October 17, 2018

Waters recently partnered with United States Pharmacopeia (USP) experts to host a webinar discussing the upcoming changes in the pending USP General Chapter on chromatography that will provide increased flexibility for gradient methods. Here’s an extended Q&A from the webinar.

Categories: Pharmaceutical
Tags: , , , , , ,

Enhancing Analytical Productivity by Breaking Down Silos (Part 1)

By July 20, 2018

Analytical methods transfer. Data integrity. A changing and more stringent regulatory landscape. All this, and more, impacts productivity in upstream and downstream biopharmaceutical processes. How is Waters looking to help address development challenges for biologics and biosimilars?

Categories: Pharmaceutical
Tags: , , , , , ,